Further evidence for plasma progranulin as a biomarker in bipolar disorder

Journal of Affective Disorders

Volumn 157, Issue , 2014, Pages 87-91

  Kittel Schneider, Sarah ^a,d   Weigl, Johannes ^a   Volkert, Julia ^a   Geßner, Alexandra ^a   Schmidt, Brigitte ^a   Hempel, Susanne ^a   Kiel, Tilman ^a   Olmes, David G ^c   Bartl, Jasmin ^b   Weber, Heike ^a   Kopf, Juliane ^a   Reif, Andreas ^a,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Biomarker; Bipolar disorder; Genetic variants; Inflammation; Neurodegeneration; Progranulin

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LITHIUM; NEUROLEPTIC AGENT; PROGRANULIN;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAMPLE SIZE; SEMI STRUCTURED INTERVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

BIOMARKER; BIPOLAR DISORDER; GENETIC VARIANTS; INFLAMMATION; NEURODEGENERATION; PROGRANULIN;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; BIPOLAR DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LITHIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84893872715     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.01.006     Document Type: Article

References (29)

1. S.H. Abbasi, F. Hosseini, A. Modabbernia, M. Ashrafi, and S. Akhondzadeh Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study J. Affect. Disord. 141 2012 308 314
2. Z. Ahmed, I.R. Mackenzie, M.L. Hutton, and D.W. Dickson Progranulin in frontotemporal lobar degeneration and neuroinflammation J. Neuroinflammation 4 2007 7
3. M.R. Almeida, I. Baldeiras, M.H. Ribeiro, B. Santiago, C. Machado, J. Massano, J. Guimaraes, C. Resende Oliveira, and I. Santana Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a portuguese cohort Neurodegener. Dis. 2013 10.1159/000352022
4. M. Alsaif, P.C. Guest, E. Schwarz, A. Reif, S. Kittel-Schneider, M. Spain, H. Rahmoune, and S. Bahn Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection Proteomics Clin. Appl. 6 2012 297 303
5. C.T. Chiu, and D.M. Chuang Neuroprotective action of lithium in disorders of the central nervous system Zhong Nan Da Xue Xue Bao Yi Xue Ban 36 2011 461 476
6. C.T. Chiu, Z. Wang, J.G. Hunsberger, and D.M. Chuang Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder Pharmacol. Rev. 65 2013 105 142
7. S. Demorrow Progranulin: a novel regulator of gastrointestinal cancer progression Transl. Gastrointest. Cancer 2 2013 145 151
8. R.C. Drexhage, E.M. Knijff, R.C. Padmos, L. Heul-Nieuwenhuijzen, W. Beumer, M.A. Versnel, and H.A. Drexhage The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder Expert Rev. Neurother. 10 2010 59 76
9. E.S.R.-D. Fähndrich Leitfaden zur Erfassung des Psychopathologischen Befundes 2007 Halbstrukturiertes Interview Anhand des AMDP-Systems Berlin Hogrefe
10. N. Finch, M. Baker, R. Crook, K. Swanson, K. Kuntz, R. Surtees, G. Bisceglio, A. Rovelet-Lecrux, B. Boeve, R.C. Petersen, D.W. Dickson, S.G. Younkin, V. Deramecourt, J. Crook, N.R. Graff-Radford, and R. Rademakers Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members Brain 132 2009 583 591
11. D. Galimberti, B. Dell×osso, C. Fenoglio, C. Villa, F. Cortini, M. Serpente, S. Kittel-Schneider, J. Weigl, M. Neuner, J. Volkert, C. Leonhard, D.G. Olmes, J. Kopf, C. Cantoni, E. Ridolfi, C. Palazzo, L. Ghezzi, N. Bresolin, A.C. Altamura, E. Scarpini, and A. Reif Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia PLoS One 7 2012 e32164
12. X. Gao, A.P. Joselin, L. Wang, A. Kar, P. Ray, A. Bateman, A.M. Goate, and J.Y. Wu Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3beta Protein Cell 1 2010 552 562
13. R. Ghidoni, L. Benussi, M. Glionna, M. Franzoni, and G. Binetti Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration Neurology 71 2008 1235 1239
14. G.M. Goodwin, A. Martinez-Aran, D.C. Glahn, and E. Vieta Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report Eur. Neuropsychopharmacol. 18 2008 787 793
15. S. Hope, T. Ueland, N.E. Steen, I. Dieset, S. Lorentzen, A.O. Berg, I. Agartz, P. Aukrust, and O.A. Andreassen Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder Schizophr. Res. 145 2013 36 42
16. J. Jakobsson, H. Zetterberg, K. Blennow, C. Johan Ekman, A.G. Johansson, and M. Landen Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder Neuropsychopharmacology 38 2013 664 672
17. J. Jian, J. Konopka, and C. Liu Insights into the role of progranulin in immunity, infection, and inflammation J. Leukoc. Biol. 93 2013 199 208
18. C. Langan, and C. Mcdonald Neurobiological trait abnormalities in bipolar disorder Mol. Psychiatry 14 2009 833 846
19. J. Margraf Diagnostisches Kurzinterview bei Psychischen Störungen: Mini-DIPS 1994 Springer Verlag Berlin Heidelberg New York.
20. R.K. Mcnamara, and F.E. Lotrich Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev. Neurother. 12 2012 1143 1161
21. P. Momeni, K. Detucci, R.E. Straub, D.R. Weinberger, P. Davies, J. Grafman, J. Hardy, and E.D. Huey Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia Neurocase 16 2010 273 279
22. H. Okura, S. Yamashita, T. Ohama, A. Saga, A. Yamamoto-Kakuta, Y. Hamada, N. Sougawa, R. Ohyama, Y. Sawa, and A. Matsuyama HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins J. Atheroscler. Thromb. 17 2010 568 577
23. R. Rademakers, J.L. Eriksen, M. Baker, T. Robinson, Z. Ahmed, S.J. Lincoln, N. Finch, N.J. Rutherford, R.J. Crook, K.A. Josephs, B.F. Boeve, D.S. Knopman, R.C. Petersen, J.E. Parisi, R.J. Caselli, Z.K. Wszolek, R.J. Uitti, H. Feldman, M.L. Hutton, I.R. Mackenzie, N.R. Graff-Radford, and D.W. Dickson Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia Hum. Mol. Genet. 17 2008 3631 3642
24. C.L. Raison, R.E. Rutherford, B.J. Woolwine, C. Shuo, P. Schettler, D.F. Drake, E. Haroon, and A.H. Miller A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers JAMA Psychiatry 70 2013 31 41
25. J.S. Rao, G.J. Harry, S.I. Rapoport, and H.W. Kim Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients Mol. Psychiatry 15 2010 384 392
26. W. Tang, Y. Lu, Q.Y. Tian, Y. Zhang, F.J. Guo, G.Y. Liu, N.M. Syed, Y. Lai, E.A. Lin, L. Kong, J. Su, F. Yin, A.H. Ding, A. Zanin-Zhorov, M.L. Dustin, J. Tao, J. Craft, Z. Yin, J.Q. Feng, S.B. Abramson, X.P. Yu, and C.J. Liu The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice Science 332 2011 478 484
27. (Pubitemid 351519762)
28. D. Xu, N. Suenaga, M.J. Edelmann, R. Fridman, R.J. Muschel, and B.M. Kessler Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach Mol. Cell. Proteomics 7 2008 2215 2228
29. J. Zhu, C. Nathan, W. Jin, D. Sim, G.S. Ashcroft, S.M. Wahl, L. Lacomis, H. Erdjument-Bromage, P. Tempst, C.D. Wright, and A. Ding Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair Cell 111 2002 867 878 (Pubitemid 36106407)